贝康医疗-B(02170)：PGT-M试剂盒获国家药监局颁发三类医疗器械证

智通财经04-29

智通财经APP讯，贝康医疗-B(02170)发布公告，公司自主研发的“胚胎植入前地中海贫血基因检测试剂盒(半导体测序法)”(PGT-M试剂盒)于2026年4月28日成功获批国家三类医疗器械注册证(注册证编号：国械注准20263400858)，成为全国首个获批上市的胚胎植入前地中海贫血检测试剂盒。该试剂盒用于定性检测体外培养胚胎的囊胚滋养层细胞及其父母双方和(或)相关亲属基因组DNA，通过连锁...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2631251557?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-04-29 19:40","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2631251557","market":"us","top_or_hot":-1,"title":"贝康医疗-B(02170)：PGT-M试剂盒获国家药监局颁发三类医疗器械证","media":"智通财经","content":"<div>\n<p>智通财经APP讯，贝康医疗-B(02170)发布公告，公司自主研发的“胚胎植入前地中海贫血基因检测试剂盒(半导体测序法)”(PGT-M试剂盒)于2026年4月28日成功获批国家三类医疗器械注册证(注册证编号： 国械注准20263400858)，成为全国首个获批上市的胚胎植入前地中海贫血检测试剂盒。该试剂盒用于定性检测体外培养胚胎的囊胚滋养层细胞及其父母双方和(或)相关亲属基因组DNA，通过连锁...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1436459.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>贝康医疗-B(02170)：PGT-M试剂盒获国家药监局颁发三类医疗器械证</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n贝康医疗-B(02170)：PGT-M试剂盒获国家药监局颁发三类医疗器械证\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-04-29 19:40 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1436459.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，贝康医疗-B(02170)发布公告，公司自主研发的“胚胎植入前地中海贫血基因检测试剂盒(半导体测序法)”(PGT-M试剂盒)于2026年4月28日成功获批国家三类医疗器械注册证(注册证编号： 国械注准20263400858)，成为全国首个获批上市的胚胎植入前地中海贫血检测试剂盒。该试剂盒用于定性检测体外培养胚胎的囊胚滋养层细胞及其父母双方和(或)相关亲属基因组DNA，通过连锁...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1436459.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1100","symbol_name":"医疗保健设备","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1436459.html","article_id":"2631251557","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2631251557","pubTimestamp":1777462801,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"本次获批的PGT-M试剂盒是国内首个针对地中海贫血家系遗传阻断的PGT-M产品，填补了我国单基因病胚胎植入前遗传学检测领域的国产空白。随着PGT-M试剂盒获批上市，集团的产品线进一步丰富，将有效带动遗传实验室业务收入增长，有望成为公司未来业绩增长的重要驱动力，并进一步巩固集团在中国三代试管婴儿基因检测试剂盒市场的领导地位。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"159883":"医疗器械","BK1100":"医疗保健设备","02170":"贝康医疗-B","BK1574":"生物医药B类股","BK1222":"医疗保健用品","09996":"沛嘉医疗-B","BK1583":"高瓴概念","BK1597":"三胎概念"},"translate_title":"Beikang Medical-B (02170): PGT-M kit was issued Class III medical device certificate by the State Food and Drug Administration","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159883":1.5,"02170":1.5,"09997":1.5,"09996":1.5},"content_text":"智通财经APP讯，贝康医疗-B(02170)发布公告，公司自主研发的“胚胎植入前地中海贫血基因检测试剂盒(半导体测序法)”(PGT-M试剂盒)于2026年4月28日成功获批国家三类医疗器械注册证(注册证编号： 国械注准20263400858)，成为全国首个获批上市的胚胎植入前地中海贫血检测试剂盒。该试剂盒用于定性检测体外培养胚胎的囊胚滋养层细胞及其父母双方和(或)相关亲属基因组DNA，通过连锁分析判断胚胎是否遗传了来自父母的基因突变，从而辅助医生选择合适的胚胎进行植入。本次获批的PGT-M试剂盒是国内首个针对地中海贫血家系遗传阻断的PGT-M产品，填补了我国单基因病胚胎植入前遗传学检测领域的国产空白。该试剂盒已参加大陆国家十四五“生育健康及妇女儿童健康保障”重点研发计划中的国产化试剂盒课题，可从根源上阻断地贫基因遗传到下一代，帮助地贫家庭生育健康的婴儿，降低出生缺陷率。公司目前维持中国PGT合规市场超过50%的市场份额，与全国约300家医院建立合作关系，共建联合实验室超过60家，深度绑定超过80家头部三代生殖中心，形成了从PGT-A、PGT-M到PGT-SR的完整PGT产品矩阵。随着PGT-M试剂盒获批上市，集团的产品线进一步丰富，将有效带动遗传实验室业务收入增长，有望成为公司未来业绩增长的重要驱动力，并进一步巩固集团在中国三代试管婴儿基因检测试剂盒市场的领导地位。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2631251557","isCrawlerRequest":true}